Cordasco Financial Network’s Amicus Therapeutics FOLD Stock Holding History

Cordasco Financial Network’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Hold	140	–	–	﹤0.01%	527
2022 Q1	$1K	Hold	140	–	–	﹤0.01%	529
2021 Q4	$2K	Hold	140	–	–	﹤0.01%	512
2021 Q3	$1K	Hold	140	–	–	﹤0.01%	541
2021 Q2	$1K	Hold	140	–	–	﹤0.01%	537
2021 Q1	$1K	Hold	140	–	–	﹤0.01%	538
2020 Q4	$3K	Hold	140	–	–	﹤0.01%	459
2020 Q3	$2K	Hold	140	–	–	﹤0.01%	473
2020 Q2	$2K	Hold	140	–	–	﹤0.01%	434
2020 Q1	$1K	Hold	140	–	–	﹤0.01%	434
2019 Q4	$1K	Hold	140	–	–	﹤0.01%	430
2019 Q3	$1K	Hold	140	–	–	﹤0.01%	455
2019 Q2	$2K	Hold	140	–	–	﹤0.01%	426
2019 Q1	$2K	Hold	140	–	–	﹤0.01%	420
2018 Q4	$1K	Hold	140	–	–	﹤0.01%	372
2018 Q3	$2K	Hold	140	–	–	﹤0.01%	336
2018 Q2	$2K	Hold	140	–	–	﹤0.01%	355
2018 Q1	$2K	Hold	140	–	–	﹤0.01%	244
2017 Q4	$2K	Hold	140	–	–	﹤0.01%	227
2017 Q3	$2K	Hold	140	–	–	﹤0.01%	221
2017 Q2	$1K	Hold	140	–	–	﹤0.01%	234
2017 Q1	$1K	Hold	140	–	–	﹤0.01%	266
2016 Q4	$1K	Buy	+140	New	+$969	﹤0.01%	225

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cordasco Financial Network's FOLD Position: Q2 2022 in Review

Cordasco Financial Network held its Amicus Therapeutics (FOLD) position steady in Q2 2022 at 140 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #527.

Cordasco Financial Network first reported a position in FOLD in Q4 2016 and has held it in 23 quarters since. The position peaked at $3K in Q4 2020. 212 funds tracked by Wall St. Rank hold FOLD as of Q2 2022.

Cordasco Financial Network held 140 shares of Amicus Therapeutics worth $2K as of Q2 2022.
Cordasco Financial Network left its Amicus Therapeutics share count unchanged in Q2 2022.
Amicus Therapeutics made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #527 holding.
Cordasco Financial Network first reported a position in Amicus Therapeutics in Q4 2016 and has held it in 23 quarters since.
Cordasco Financial Network's Amicus Therapeutics position peaked at $3K in Q4 2020.
212 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.